跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TASULOSE PROLONGED-RELEASE FILM-COATED TABLETS 400 mcg - HSA Drug Approval Details
Approvals
/
HSA
/
TASULOSE PROLONGED-RELEASE FILM-COATED TABLETS 400 mcg
Approved
THERAPEUTIC
TASULOSE PROLONGED-RELEASE FILM-COATED TABLETS 400 mcg
Lek Pharmaceuticals d.d. (Ljubljana)Lek Pharmaceuticals d.d. (Lendava) (Primary and Secondary Packager)
🇸🇬 Health Sciences Authority
Approval Date
Nov 1, 2018
Approval ID
a32af7c373962365
Company
Lek Pharmaceuticals d.d. (Ljubljana)Lek Pharmaceuticals d.d. (Lendava) (Primary and Secondary Packager)
Type
Therapeutic
Approval Details
Approval Id
a32af7c373962365
Drug Name
TASULOSE PROLONGED-RELEASE FILM-COATED TABLETS 400 mcg
Product Name
TASULOSE PROLONGED-RELEASE FILM-COATED TABLETS 400 mcg
Approval Number
SIN15573P
Approval Date
2018-11-01
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Licence Holder
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route Of Administration
ORAL
Atc Code
G04CA02
Atc Item Name
tamsulosin
Pharma Manufacturer Name
SANDOZ SINGAPORE PTE. LTD.
Company Detail Path
/organization/sandoz-singapore-pte-ltd
Active Ingredients
Tamsulosin hydrochloride
0.4mg
Tamsulosin hydrochloride
0.4mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 1, 2018
Approval ID
a32af7c373962365
Type
Therapeutic
Back to HSA Approvals
